Searched for
FRESENIUS
Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...- Complaint filed against Natco Pharma in US by Fresenius KabiNatco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled s...
- Fresenius acquires 85 per cent stake in Sandor Nephro ServicesEstablished in 2011, Sandor Nephro Services operates around 55 dialysis centres while Fresenius Medical Care runs three such centres across...
- Fresenius Kabi gets 2 months extension for delisting offerFresenius Kabi Oncology today said Securities Appellate Tribunal (SAT) has granted it an extension of two months to complete its delisting ...
- USFDA issues warning letter to Fresenius Kabi OncologyUS health regulator has issued a warning letter to Fresenius Kabi Oncology for violation of manufacturing norms at its Kalyani facility in ...
- USFDA issues warning letter to Fresenius Kabi OncologyFresenius Kabi Oncology today said it has received a warning letter from the US health regulator asking for more information and implementa...
- Fresenius files patent infringements suit against DRL in USFresenius Kabi has dragged leading pharmaceuticals company Dr Reddy's to court for allegedly infringing on the former's patented anaestheti...
- Promoters want to delist Fresenius Kabi Oncology from boursesFresenius Kabi (Singapore) Pte Ltd is planning to delist its Indian arm Fresenius Kabi Oncology by buying out 19 % stake held by the public.
- Parenteral Drugs to sell unit to Fresenius Kabi for Rs 200 crParenteral Drugs today said its subsidiary, Goa Formulations has entered into an agreement with Fresenius Kabi India to sell its manufactur...
- Buy Fresenius Kabi Oncology with a target of 108: Sandeep WagleFresenius Kabi Oncology Ltd is a ‘BUY’ call with a target of Rs 108 and a stop loss of Rs 92.50.
- Fresenius Kabi to pay higher compensation to clinical trial victimsFresenius Kabi Oncology, the Indian arm of Germany's Fresenius Kabi will increase the compensation it paid to families of two volunteers wh...
- Fresenius Kabi's India unit now global R&D hubFresenius Kabi Oncology has restructured its business, making it one of the global R&D and manufacturing hubs for the German promoter.
- Germany's Fresenius recalls India-made drugs shipped to USGerman drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.
- Fresenius Kabi allots 0.99% stake to Atlas VermoegansverwaltunghFresenius Kabi Oncology (formerly Dabur Pharma) is making a preferential allotment of 15.5 lakh shares amounting to 0.99% stake to Frankfur...
- Dabur Pharma gets Government nod for name changeDabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.
- Fresenius Kabi to invest 30 mn euros in Dabur’s API plantFresenius Kabi, which acquired the Burmans’ pharma business early this year, will invest around 30 euros million in the active pharmaceutic...
- Fresenius secures $2.4 billion loan for APP buyGerman healthcare group Fresenius has secured a $2.4 billion credit facility to finance its $3.7 billion acquisition of U.S. company APP Ph...
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
Load More
